Jasper Therapeutics, Inc.·4

Feb 20, 7:22 PM ET

Tucker Edwin Jonathan 4

4 · Jasper Therapeutics, Inc. · Filed Feb 20, 2024

Insider Transaction Report

Form 4
Period: 2024-02-15
Tucker Edwin Jonathan
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-15+45,00045,000 total
    Exercise: $17.95Exp: 2034-02-15Voting Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file
  • 4
    ownership.xmlPrimary